C
Constellation Pharmaceuticals
Biotech & Life Sciences · Cambridge, United States · Founded 2008 · IPO 2018
Develops drugs in the field of epigenetics focusing on selective regulators of its function MoreLess
Constellation Pharmaceuticals operates in the biopharmaceutical industry, focusing on the development of innovative therapies targeting epigenetic regulators to treat cancer. The company leverages its integrated epigenetics platform to understand the biology of gene expression regulation and develop small molecule product candidates that selectively modulate the activity of these regulators. Constellation Pharmaceuticals primarily serves patients with cancer, aiming to provide new treatment options through its clinical development programs, which are supported by novel biomarker strategies. The company's business model revolves around research and development, clinical trials, and eventual commercialization of its therapeutic candidates. Revenue is generated through partnerships, licensing agreements, and potential future sales of approved therapies. Keywords: epigenetics, cancer therapy, gene expression, small molecules, clinical trials, biomarkers, biopharmaceutical, oncology, drug development, innovative therapies.
Talent graph
Constellation Pharmaceuticals's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Constellation Pharmaceuticals has talent and traffic
Patent intelligence
$107M patent portfolio · 66 active families
Where Constellation Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Constellation Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Constellation Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Constellation Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Constellation Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.